Pubblicazioni

Human estrogen receptor Î± antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants

2022 - EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Kurtanovic, N.; Tomasevic, N.; Matic, S.; Mitrovic, M. M.; Kostic, D. A.; Sabatino, M.; Antonini, L.; Ragno, R.; Mladenovic, M.

The importance of tumor stem cells in glioblastoma resistance to therapy

2021 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Mattei, V.; Santilli, F.; Martellucci, S.; Monache, S. D.; Fabrizi, J.; Colapietro, A.; Angelucci, A.; Festuccia, C.

Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK

2021 - CELL REPORTS

Masi, I.; Caprara, V.; Spadaro, F.; Chellini, L.; Sestito, R.; Zancla, A.; Rainer, A.; Bagnato, A.; Rosano, L.

Aptamer-based in vivo therapeutic targeting of glioblastoma

2020 - MOLECULES

Cesarini, V.; Scopa, C.; Silvestris, D. A.; Scafidi, A.; Petrera, V.; Del Baldo, G.; Gallo, A.

Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences

2019 - JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Cirone, M.; Gilardini Montani, M. S.; Granato, M.; Garufi, A.; Faggioni, A.; D'Orazi, G.

Biological rationale for targeting MEK/ERK pathways in anti-cancer therapy and to potentiate tumour responses to radiation

2019 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Marampon, F.; Ciccarelli, C.; Zani, B. M.

The safety of available treatments options for neuroendocrine tumors

2017 - EXPERT OPINION ON DRUG SAFETY

Faggiano, A.; Lo Calzo, F.; Pizza, G.; Modica, R.; Colao, A.

Metabolite profiling of ascidian Styela plicata using LCâMS with multivariate statistical analysis and their antitumor activity

2017 - JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Palanisamy, S. K.; Trisciuoglio, D.; Zwergel, C.; Del Bufalo, D.; Mai, A.

Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure

2015 - EXPERT REVIEW OF ANTICANCER THERAPY

Onesti, CONCETTA ELISA; Romiti, Adriana; Roberto, Michela; Falcone, Rosa; Marchetti, Paolo

ErbB-3 activation by NRG-1Î² sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)

2015 - ONCOTARGET

Prasetyanti, Pramudita R.; Capone, Emily; Barcaroli, Daniela; D'Agostino, Daniela; Volpe, Silvia; Benfante, Antonina; van Hooff, Sander; Iacobelli, Valentina; Rossi, Cosmo; Iacobelli, Stefano; Medema, Jan Paul; de Laurenzi, Vincenzo; Sala, Gianluca